Schrödinger, Inc.

NasdaqGS:SDGR Stock Report

Market Cap: US$1.5b

Schrödinger Future Growth

Future criteria checks 1/6

Schrödinger is forecast to grow earnings and revenue by 9.7% and 17.3% per annum respectively. EPS is expected to grow by 10.4% per annum. Return on equity is forecast to be -35% in 3 years.

Key information

9.7%

Earnings growth rate

10.4%

EPS growth rate

Healthcare Services earnings growth30.5%
Revenue growth rate17.3%
Future return on equity-35.0%
Analyst coverage

Good

Last updated29 Aug 2024

Recent future growth updates

Recent updates

Schrodinger: More Drug Discovery Validation

Aug 06

Here's Why We're Watching Schrödinger's (NASDAQ:SDGR) Cash Burn Situation

Aug 05
Here's Why We're Watching Schrödinger's (NASDAQ:SDGR) Cash Burn Situation

We Think The Compensation For Schrödinger, Inc.'s (NASDAQ:SDGR) CEO Looks About Right

Jun 12
We Think The Compensation For Schrödinger, Inc.'s (NASDAQ:SDGR) CEO Looks About Right

Schrödinger: More Pharmaceutical Than Software

May 07

Schrödinger, Inc. (NASDAQ:SDGR) Not Flying Under The Radar

May 02
Schrödinger, Inc. (NASDAQ:SDGR) Not Flying Under The Radar

Schrödinger, Inc. (NASDAQ:SDGR) Analysts Just Cut Their EPS Forecasts Substantially

Mar 01
Schrödinger, Inc. (NASDAQ:SDGR) Analysts Just Cut Their EPS Forecasts Substantially

Schrodinger: Conservative Guidance Sets The Stock Up For A Solid 2024

Mar 01

Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?

Feb 28
Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?

The Price Is Right For Schrödinger, Inc. (NASDAQ:SDGR) Even After Diving 26%

Feb 01
The Price Is Right For Schrödinger, Inc. (NASDAQ:SDGR) Even After Diving 26%

Schrödinger, Inc.'s (NASDAQ:SDGR) P/S Still Appears To Be Reasonable

Dec 18
Schrödinger, Inc.'s (NASDAQ:SDGR) P/S Still Appears To Be Reasonable

Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?

Sep 28
Is Now An Opportune Moment To Examine Schrödinger, Inc. (NASDAQ:SDGR)?

Is There An Opportunity With Schrödinger, Inc.'s (NASDAQ:SDGR) 49% Undervaluation?

Jul 01
Is There An Opportunity With Schrödinger, Inc.'s (NASDAQ:SDGR) 49% Undervaluation?

Schrödinger: Q2 Earnings Supports Growth Narrative

Aug 26

Schrödinger appoints Dr. Geoffrey Porges as finance chief

Aug 18

Sizing Up Schrodinger

Jun 06

Schrödinger: Holding The Keys To Discovery

Mar 26

Schrodinger: A Long-Term Hold For Biotech Investors With Upside Potential Too

Mar 15

Schrödinger: Conviction Remains High, Q4 Report And Guidance Will Be Critical

Jan 06

After Its Stock Price Doubled Last Year, Why Schrödinger Is Slumping Now

Nov 24

We're Interested To See How Schrödinger (NASDAQ:SDGR) Uses Its Cash Hoard To Grow

Nov 12
We're Interested To See How Schrödinger (NASDAQ:SDGR) Uses Its Cash Hoard To Grow

An Intrinsic Calculation For Schrödinger, Inc. (NASDAQ:SDGR) Suggests It's 38% Undervalued

Oct 05
An Intrinsic Calculation For Schrödinger, Inc. (NASDAQ:SDGR) Suggests It's 38% Undervalued

Schrodinger: An Investment In Drug Discovery In Addition To Software Sales

Sep 20

Earnings and Revenue Growth Forecasts

NasdaqGS:SDGR - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026302-164-124N/A6
12/31/2025261-176-174N/A11
12/31/2024210-174-217N/A11
6/30/2024201-201-193-180N/A
3/31/2024188-143-159-145N/A
12/31/202321741-150-137N/A
9/30/202319944-137-124N/A
6/30/202319466-115-105N/A
3/31/202319714-121-111N/A
12/31/2022181-149-128-120N/A
9/30/2022170-153-122-114N/A
6/30/2022163-148-102-95N/A
3/31/2022154-135-108-99N/A
12/31/2021138-100-78-71N/A
9/30/2021125-81-14-7N/A
6/30/2021121-42-13-9N/A
3/31/2021114-11912N/A
12/31/2020108-241417N/A
9/30/2020101-20-40-38N/A
6/30/202095-35-34-32N/A
3/31/202091-33-29-27N/A
12/31/201986-25-28-26N/A
9/30/201977-24-26-24N/A
6/30/201970-24-29-25N/A
3/31/201969-29-29-25N/A
12/31/201867-28-29-24N/A
12/31/201756-17N/A-15N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: SDGR is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: SDGR is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: SDGR is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: SDGR's revenue (17.3% per year) is forecast to grow faster than the US market (8.8% per year).

High Growth Revenue: SDGR's revenue (17.3% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: SDGR is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y